Inicio › Enfermedad de obstrucción pulmonar crónica › Pensilvania › Philadelphia
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Philadelphia, PA
26 estudios para Enfermedad de obstrucción pulmonar crónica buscan participantes en centros de Philadelphia y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Reclutando
- Temple University - Temple Lung Center, Philadelphia
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Reclutando
- Temple University Hospital, Philadelphia
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
ReclutandoFase 2
- DM Clinical Research - Philadelphia, Philadelphia
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2
- Research Site, Philadelphia
- Research Site, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Suburban Research Associates - Media- Site Number : 8400143, Media · A 12 mi de distancia
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2/3
- Temple University Hospital, Philadelphia
- Temple Health Oaks, Phoenixville · A 22 mi de distancia
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Reclutando
- Temple University, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Temple University Hospital- Site Number : 8400059, Philadelphia
STRIVE Post-Market Registry Study
ReclutandoEstudio observacional
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
ReclutandoFase 3
- Research Site, Horsham · A 16 mi de distancia
- Research Site, Wilmington · A 25 mi de distancia
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ReclutandoFase 3
- GSK Investigational Site, Philadelphia
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Wilmington · A 25 mi de distancia
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutandoFase 3
- Research Site, Philadelphia
- Research Site, Philadelphia
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Reclutando
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
ReclutandoFase 2
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutandoFase 3
- Research Site, Philadelphia
COPD Exacerbation Follow Up
ReclutandoEstudio observacional
- Thomas Jefferson University, Philadelphia
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, West Chester · A 24 mi de distancia
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Reclutando
- Temple University Hospital, Philadelphia
SPIROMICS Study of Early COPD Progression (SOURCE)
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Temple University, Philadelphia
Feasibility of Semaglutide in Advanced Lung Disease
ReclutandoFase 1/2
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
ReclutandoEstudio observacional
- Thomas Jefferson University, Philadelphia
Supporting Evidence-based Responses to Emotional Needs in Emphysema
Reclutando
- University of Pennsylvania, Philadelphia
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
ReclutandoEstudio observacional
- Temple University, Philadelphia
Temple Health Chest Initiative (THCI 2.0)
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Reclutando
- Jeanes Hospital, Philadelphia
- Temple University, Philadelphia
Más información sobre Enfermedad de obstrucción pulmonar crónica en MedlinePlus
Ensayos de Enfermedad de obstrucción pulmonar crónica en otras ciudades
- Miami, FL20 estudios
- Houston, TX18 estudios
- Birmingham, AL17 estudios
- Baltimore, MD16 estudios
- Boston, MA15 estudios
- Orlando, FL15 estudios
- Chicago, IL15 estudios
- Dallas, TX13 estudios
- New York City, NY12 estudios
- Pittsburgh, PA11 estudios
- Winston-Salem, NC11 estudios
- Hialeah, FL10 estudios
Otros estudios en Philadelphia
- Cáncer (todos los tipos)57 estudios
- Cáncer de seno51 estudios
- Cáncer de pulmón de células no pequeñas49 estudios
- Cáncer de ovario47 estudios
- Cáncer metastásico42 estudios
- Cáncer del colon y del recto41 estudios
- Cáncer de próstata41 estudios
- Cáncer de pulmón36 estudios
- Leucemia mielógena aguda33 estudios
- Fallo cardíaco31 estudios
- Cáncer de endometrio29 estudios
- Cáncer de páncreas26 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.